→
Salesforce, Inc. has a market capitalization of $158.73B and current trading at $166.04, reflecting a decrease of approximately 0.27% from the previous close of $166.49. The company's P/E ratio stands at 21.29, with a year-over-year EPS growth of 22.64% and revenue growth of 9.58%. The stock's 52-week range is between $161 and $277, indicating volatility in its price.
Salesforce, Inc. presents a mix of growth potential and financial challenges that may influence investor decision-making.
Some investors cite Salesforce's robust EPS growth of 22.64% and a relatively low debt-to-equity ratio of 0.18 as indicators of strong financial health. Additionally, the company's recent contracts, such as the partnership with CVS Health for enhanced call center solutions, could drive future revenue growth.
Concerns arise from Salesforce's current ratio of 0.76, which may indicate potential liquidity issues. The stock's price decline from a 52-week high of $277 raises questions about its valuation amidst increasing competition and market volatility.
Want AI analysis of your entire portfolio?
Helm Terminal connects to your brokerage, analyzes every holding, and delivers actionable intelligence weekly.
Get started freeHelm provides financial data for informational purposes only. This is not financial, investment, or tax advice. Consult a qualified professional before making financial decisions.
Salesforce, Inc. has a market capitalization of $158.73B and current trading at $166.04, reflecting a decrease of approximately 0.27% from the previous close of $166.49. The company's P/E ratio stands at 21.29, with a year-over-year EPS growth of 22.64% and revenue growth of 9.58%. The stock's 52-week range is between $161 and $277, indicating volatility in its price.
Concerns arise from Salesforce's current ratio of 0.76, which may indicate potential liquidity issues. The stock's price decline from a 52-week high of $277 raises questions about its valuation amidst increasing competition and market volatility.
Some investors cite Salesforce's robust EPS growth of 22.64% and a relatively low debt-to-equity ratio of 0.18 as indicators of strong financial health. Additionally, the company's recent contracts, such as the partnership with CVS Health for enhanced call center solutions, could drive future revenue growth.
Some investors cite Salesforce's robust EPS growth of 22.64% and a relatively low debt-to-equity ratio of 0.18 as indicators of strong financial health. Additionally, the company's recent contracts, such as the partnership with CVS Health for enhanced call center solutions, could drive future revenue growth. Concerns arise from Salesforce's current ratio of 0.76, which may indicate potential liquidity issues. The stock's price decline from a 52-week high of $277 raises questions about its valuation amidst increasing competition and market volatility.
Salesforce, Inc. has a market capitalization of $158.73B and current trading at $166.04, reflecting a decrease of approximately 0.27% from the previous close of $166.49. The company's P/E ratio stands at 21.29, with a year-over-year EPS growth of 22.64% and revenue growth of 9.58%. The stock's 52-week range is between $161 and $277, indicating volatility in its price.
Helm's analysis is generated by an AI model from live market data. It identifies risk signals, opportunities, and key metrics based on current fundamentals, recent price action, and analyst consensus. It does not execute trades, issue certified investment advice, or predict future prices.
Not financial advice. Informational use only. AI-generated content may contain errors. Consult a licensed financial advisor before making investment decisions. Helm Terminal is not registered as an investment advisor.
Helm Terminal offers free AI-powered stock analysis for CRM at helmterminal.dev/analyze/CRM, updated continuously during US market hours. No signup required.